ANIK
Price
$8.94
Change
-$0.15 (-1.65%)
Updated
Sep 5 closing price
Capitalization
128.9M
54 days until earnings call
BLOZF
Price
$0.41
Change
-$0.01 (-2.38%)
Updated
Sep 5 closing price
Capitalization
50.91M
Interact to see
Advertisement

ANIK vs BLOZF

Header iconANIK vs BLOZF Comparison
Open Charts ANIK vs BLOZFBanner chart's image
Anika Therapeutics
Price$8.94
Change-$0.15 (-1.65%)
Volume$67.47K
Capitalization128.9M
Cannabix Technologies
Price$0.41
Change-$0.01 (-2.38%)
Volume$102.61K
Capitalization50.91M
ANIK vs BLOZF Comparison Chart in %
Loading...
ANIK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLOZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIK vs. BLOZF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIK is a Hold and BLOZF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ANIK: $8.94 vs. BLOZF: $0.41)
Brand notoriety: ANIK and BLOZF are both not notable
ANIK represents the Pharmaceuticals: Generic, while BLOZF is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ANIK: 49% vs. BLOZF: 129%
Market capitalization -- ANIK: $128.9M vs. BLOZF: $50.91M
ANIK [@Pharmaceuticals: Generic] is valued at $128.9M. BLOZF’s [@Medical/Nursing Services] market capitalization is $50.91M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIK’s FA Score shows that 0 FA rating(s) are green whileBLOZF’s FA Score has 0 green FA rating(s).

  • ANIK’s FA Score: 0 green, 5 red.
  • BLOZF’s FA Score: 0 green, 5 red.
According to our system of comparison, BLOZF is a better buy in the long-term than ANIK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIK’s TA Score shows that 3 TA indicator(s) are bullish while BLOZF’s TA Score has 3 bullish TA indicator(s).

  • ANIK’s TA Score: 3 bullish, 5 bearish.
  • BLOZF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, BLOZF is a better buy in the short-term than ANIK.

Price Growth

ANIK (@Pharmaceuticals: Generic) experienced а -4.69% price change this week, while BLOZF (@Medical/Nursing Services) price change was -1.54% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.

Reported Earning Dates

ANIK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Medical/Nursing Services (-0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANIK($129M) has a higher market cap than BLOZF($50.9M). BLOZF YTD gains are higher at: 77.407 vs. ANIK (-45.687). ANIK has higher annual earnings (EBITDA): -2.24M vs. BLOZF (-3.11M). ANIK has more cash in the bank: 53.2M vs. BLOZF (2.85M). BLOZF has less debt than ANIK: BLOZF (50K) vs ANIK (25M). ANIK has higher revenues than BLOZF: ANIK (115M) vs BLOZF (0).
ANIKBLOZFANIK / BLOZF
Capitalization129M50.9M253%
EBITDA-2.24M-3.11M72%
Gain YTD-45.68777.407-59%
P/E RatioN/AN/A-
Revenue115M0-
Total Cash53.2M2.85M1,867%
Total Debt25M50K50,000%
FUNDAMENTALS RATINGS
ANIK vs BLOZF: Fundamental Ratings
ANIK
BLOZF
OUTLOOK RATING
1..100
793
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
6550
P/E GROWTH RATING
1..100
74100
SEASONALITY SCORE
1..100
2950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BLOZF's Valuation (52) in the null industry is somewhat better than the same rating for ANIK (92) in the Pharmaceuticals Other industry. This means that BLOZF’s stock grew somewhat faster than ANIK’s over the last 12 months.

BLOZF's Profit vs Risk Rating (95) in the null industry is in the same range as ANIK (100) in the Pharmaceuticals Other industry. This means that BLOZF’s stock grew similarly to ANIK’s over the last 12 months.

ANIK's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as BLOZF (98) in the null industry. This means that ANIK’s stock grew similarly to BLOZF’s over the last 12 months.

BLOZF's Price Growth Rating (50) in the null industry is in the same range as ANIK (65) in the Pharmaceuticals Other industry. This means that BLOZF’s stock grew similarly to ANIK’s over the last 12 months.

ANIK's P/E Growth Rating (74) in the Pharmaceuticals Other industry is in the same range as BLOZF (100) in the null industry. This means that ANIK’s stock grew similarly to BLOZF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIKBLOZF
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
63%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
70%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
71%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANIK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLOZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPRUY27.830.62
+2.28%
Kering SA
KLKBY5.29N/A
N/A
Kuala Lumpur Kepong Berhad
VTEPF0.63N/A
N/A
VIDENDUM PLC
PHCCF7.05N/A
N/A
PHC Holdings Corp.
ENTEF0.06N/A
-1.38%
ESE Entertainment Inc.

ANIK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIK has been loosely correlated with AVNS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIK jumps, then AVNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIK
1D Price
Change %
ANIK100%
-1.65%
AVNS - ANIK
37%
Loosely correlated
+0.47%
FLGT - ANIK
34%
Loosely correlated
-0.14%
ORGO - ANIK
33%
Poorly correlated
-0.60%
LIVN - ANIK
32%
Poorly correlated
-0.31%
INFU - ANIK
30%
Poorly correlated
-4.42%
More

BLOZF and

Correlation & Price change

A.I.dvisor tells us that BLOZF and ANIK have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BLOZF and ANIK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLOZF
1D Price
Change %
BLOZF100%
-0.45%
ANIK - BLOZF
26%
Poorly correlated
-1.65%
STVN - BLOZF
23%
Poorly correlated
+4.82%
PXMBF - BLOZF
23%
Poorly correlated
N/A
NPCE - BLOZF
21%
Poorly correlated
+1.25%
ANPCF - BLOZF
20%
Poorly correlated
N/A
More